Detalles de la búsqueda
1.
Safety and biological outcomes following a phase 1 trial of GD2-specific CAR-T cells in patients with GD2-positive metastatic melanoma and other solid cancers.
J Immunother Cancer
; 12(5)2024 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38754916
2.
Silver In Situ Hybridization for the Rapid Assessment of MDM2 Amplification in Soft Tissue and Bone Tumors. Validation Based on an Audit of 192 Consecutive Cases Evaluated by Silver In Situ Hybridization and Fluorescence In Situ Hybridization.
Appl Immunohistochem Mol Morphol
; 31(2): 101-106, 2023 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36692149
Resultados
1 -
2
de 2
1
Próxima >
>>